Skip to content

Prevention technologies

Treatment switches on basis of CD4 declines often unnecessary, Uganda research shows

Disadvantage of late treatment start in Africa may persist for years, studies find

Hepatitis C in HIV-positive gay men: Amsterdam, Paris, New York and UK compared

Hormonal contraception does not affect HIV progression in large international cohort

High failure rate for people with low CD4 nadirs in Kaletra monotherapy study

Serosorting raises the risk of STIs and HIV for German gay men

Tenofovir provides good hepatitis B virus suppression in HIV/HBV co-infected patients

Men becoming visible: more light shed on men who have sex with men in Africa and India